SUMMARY
thermore, among maintenance hemodialysis (HD) patients, LVH is common because of volume overload and hypertension resulting from renal disease.3, Heart diseases account for approximately 40% of all causes of death in maintenance HD patients.3,5) Therefore, LVH seems to be a very important factor that worsens their prognosis. The renin-angiotensin system has been shown to be an important system that regulates blood pressure and homeostasis of body fluid, and abnormalities in the system may be involved in the development of cardiovascular diseases. Recently, several gene polymorphisms, such as the ACE, angiotensinogen and angiotensin II type 1 receptor genes, have been reported to be associated with cardiovascular disorders by many investigators, including our group.6) In particular, since Cambiens et al. reported the association of this ACE gene polymorphism with the development of myocardial infarction,7) ACE gene I/D polymorphism has been shown to be associated with not only ischemic heart disease8,9) but also LVH,10,11) cardiomyopathy,12) cerebral infarction,13) diabetic nephropathy4) and restenosis after PTCA.15) However, opposite findings have also been reported. 16,) Although there have been many studies examining the relationship between ACE gene polymorphism and LVH, the subjects were from general populations free of advanced renal failure. Studies in patients who are under volume overload, such as HD patients, have never been studied. Compared to hypertensive patients with LVH, maintenance HD patients are exposed to prominent volume overload because of renal failure and arterio-venous fistula.18) The involvement of the ACE gene polymorphism in LVH may be different in these patients from those with LVH induced by pressure overload. In order to study the involvement of ACE gene polymorphism in volume overload induced LVH, we examined it in maintenance HD patients and attempted to identify factors which are involved in LVH in these patients.
SUBJECTS AND METHODS

Patient population:
The subjects were randomly selected from patients who had been under maintenance HD. Patients who had a history of myocardial infarction, valvular heart disease or dilated cardiomyopathy were excluded from the study. Eighty patients, aged from 40 to 72 years old, were subsequently enrolled in the study. Informed consent was obtained after thorough explanation of the purpose and protocol of the study. Causative renal diseases included chronic glomerulonephritis (29%), diabetic nephropathy (38%) and nephrosclerosis (13%). History of hypertension was positive in 58 of the 80 patients and 33 were under antihypertensive treatment. 
RESULTS
Chronic glomerulonephritis and diabetic nephropathy were the two major causative renal diseases, as is consistent with the prevalence reported in Japan.21 Thirty-three of 58 patients who had a history of hypertension were taking antihypertensive drugs. No significant differences in the distribution of ACE genotype were found in relation to gender, history of hypertension or causative renal disease.
In the analyses of variance of LVMI among ACE genotype subgroups, there were no significant differences in LVMI among the entire subject population or among the clinical subgroups (Table I) . However, when LVMI was analyzed in clinical subgroups ignoring the ACE genotype, there were significant differences in LVMI between males and females (p=0.04), between the presence and absence of antihypertensive drug treatment (p=0.007) and between above or equal to and below median value of weight gain during each hemodialysis interval (p=0.01). When analyzed by multiple linear regression analysis, LVMI exhibited a significant relationship with serum creatinine, male gender, the presence of antihypertensive drug treatment, averaged weight gain between two successive HDs and mean blood pressure after HDs, but not with age, ACE genotype, hematocrit or duration of HD (Table II) . Although we also performed other multiple linear regression analyses which took into consideration ACE genotype, history of hypertension, clinical characteristics, laboratory data, CTR and HD data as independent variables, LVMI was found to have no definite relationship with any. In this study, we included patients who had antihypertensive drug treatment that might reduce LVMI. However, even these patients had higher LVMI and were found to be associated with LVMI in multiple regression analysis. This is because these patients may be under larger pressure overload than those who did not need to take antihypertensive drugs. This finding also suggests that the HD patient is not merely a simple volume overload model, but also a multifactorial one. LVH is very important in predicting prognosis among patients with chronic renal failure. In 1995, the Japanese Society for Dialysis Therapy conducted a statistical survey in Japan and received replies from 2866 facilities (99.82%).2 The survey found a gross annual mortality rate of 9.7%, of which 25.4% was from heart failure, 13.5% from cerebrovascular accident and 7.5% from myocardial infarction. In other words, the cause of death in 46.4% of the cases was either a cardiovascular or a cerebrovascular event. Several studies have shown that show LVH is strongly associated with cardiovascular or cerebrovascular events in chronic renal failure patients.43-45) Therefore, it is very important to investigate the cause of LVH and prevent it. According to the present findings, average weight gain between each dialysis was significantly associated with LVH. Thus, for the prevention of LVH in dialysis patients, not only medical treatment but also a modification of life style is of great importance.
The present study has some limitations. First, the sample volume was relatively small and the D/D genotype accounted for only 10%, which might create some bias in subjects. However, the relatively low frequency of the D/D genotype might be due to ethnic differences.46) Secondly, we did not use magnetic resonance imaging or electrocardiography but rather echocardiography to calculate left ventricular mass. Estimating left ventricular mass using electrocardiography is thought to be somewhat unreliable47) in comparison with the other two methods. At present, although magnetic resonance imaging is thought to produce the highest quality LVMI assessment, it is complicated and expensive. However, since we excluded myocardial infarction and valvular heart disease in order to minimize the estimation error for left ventricular mass, our estimation of left ventricular mass may be adequate.
In conclusion, the present findings support the concept that the HD patient can be not only a volume-overload but also a pressure-overload model because antihypertensive drug administration and weight gain between each hemodialysis influence left ventricular mass in these patients. However, ACE gene polymorphism has little association with left ventricular hypertrophy in these patients, suggesting that this polymorphism is not involved in left ventricular hypertrophy in HD patients.
